Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Affiliations

¹ Department of Urology, Loyola University Medical Center Department of Public Health Sciences Department of Medicine, Loyola University Chicago, Maywood, Illinois.

Comment

Petar Bajic et al. J Urol. 2019 Mar.

. 2019 Mar;201(3):453-454.

doi: 10.1016/j.juro.2018.09.050.

¹ Department of Urology, Loyola University Medical Center Department of Public Health Sciences Department of Medicine, Loyola University Chicago, Maywood, Illinois.

No abstract available

Comment on

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Clinical Trial.